Licochalcone A-loaded solid lipid nanoparticles improve antischistosomal activity in vitro and in vivo

Nanomedicine (Lond). 2021 Aug;16(19):1641-1655. doi: 10.2217/nnm-2021-0146. Epub 2021 Jul 14.

Abstract

Aim: To isolate licochalcone A (LicoA) from licorice, prepare LicoA-loaded solid lipid nanoparticles (L-SLNs) and evaluate the L-SLNs in vitro and in vivo against Schistosoma mansoni. Materials & methods: LicoA was obtained by chromatographic fractionation and encapsulated in SLNs by a modified high shear homogenization method. Results: L-SLNs showed high encapsulation efficiency, with satisfactory particle size, polydispersity index and Zeta potential. Transmission electron microscopy revealed that L-SLNs were rounded and homogenously distributed. Toxicity studies revealed that SLNs decreased the hemolytic and cytotoxic properties of LicoA. Treatment with L-SLNs showed in vivo efficacy against S. mansoni. Conclusion: L-SLNs are efficient in reducing worm burden and SLNs may be a promising delivery system for LicoA to treat S. mansoni infections.

Keywords: Schistosoma mansoni; licorice; nanotechnology; natural products; schistosomicidal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chalcones*
  • Drug Carriers
  • Lipids
  • Nanoparticles*
  • Particle Size

Substances

  • Chalcones
  • Drug Carriers
  • Lipids
  • licochalcone A